Company Filing History:
Years Active: 2015-2024
Title: Ansgar Erlenkoetter: Innovator in Dialysis Technology
Introduction
Ansgar Erlenkoetter is a notable inventor based in St. Wendel, Germany. He has made significant contributions to the field of dialysis technology, holding two patents that enhance the effectiveness and safety of dialysis procedures. His work is particularly relevant in the medical field, where precision and reliability are paramount.
Latest Patents
Erlenkoetter's latest patents include a device and method for determining residual blood in a dialyzer. This invention relates to a device that comprises a holding device configured to accommodate a dialyzer, an image capturing device that captures images of the dialyzer, and a control device that determines residual blood information based on statistical analysis of the captured images. Additionally, he has developed a method for using a sterilization agent to enhance hemocompatibility, which involves a sterilization agent capable of generating reactive oxygen species under sterilization conditions.
Career Highlights
Ansgar Erlenkoetter is associated with Fresenius Medical Care Deutschland GmbH, a leading company in the field of dialysis products and services. His work at this company has allowed him to focus on innovations that improve patient outcomes in dialysis treatment.
Collaborations
Throughout his career, Erlenkoetter has collaborated with notable colleagues such as Thorsten Fehr and Claus Haupert. These collaborations have contributed to the advancement of dialysis technology and the development of new medical devices.
Conclusion
Ansgar Erlenkoetter's contributions to dialysis technology through his patents and work at Fresenius Medical Care highlight his commitment to improving medical practices. His innovations are essential for enhancing patient care in the field of dialysis.